Podcast Episodes
Back to Search
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 1
Episode 19
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer questions focused on the optimizing BTK inhibitor thera…
5 years, 6 months ago
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 3
Episode 20
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from a live Webinar focused on optim…
5 years, 6 months ago
Clinical Considerations for <em>RET</em> Fusion–Positive NSCLC
Episode 16
In this podcast episode, listen to lung cancer experts Joshua Bauml, MD, a medical oncologist, and Dara L. Aisner, MD, PhD, a molecular pathologist, …
5 years, 6 months ago
Chronic Lymphocytic Leukemia: New Horizons With BTK Inhibitors: FAQ Part 2
Episode 18
In this episode, Jeff P. Sharman, MD, Danielle M. Brander, MD, and Nicole Lamanna, MD, answer audience questions from a live Webinar focused on optim…
5 years, 6 months ago
CAR T Cell Therapy for Lymphoma, Leukemia, and Myeloma: Experts Answer Clinician Questions
Episode 17
In this episode, Michael R. Bishop, MD; Daniel J. DeAngelo, MD, PhD; and Noopur Raje, MD, answer clinician questions on current best practices and em…
5 years, 7 months ago
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond
Episode 15
In this episode, an expert medical oncology panel, led by Elizabeth R. Plimack, MD, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses cur…
5 years, 7 months ago
FAQ on New Therapeutic Developments in Relapsed/Refractory Multiple Myeloma
Episode 14
In this episode, Jesús F. San-Miguel, MD, PhD; Paula Rodriguez-Otero, MD, PhD; and Prof. Dr. med. Katja Weisel answer questions focused on current a…
5 years, 7 months ago
New Advances in Relapsed/Refractory Multiple Myeloma: Frequently Asked Questions on Current and Emerging Treatments
Episode 13
In this episode, Natalie S. Callander, MD, and Shaji Kumar, MD, answer audience questions from a live CCO Webinar on relapsed/refractory myeloma rega…
5 years, 7 months ago
Practical Application of Immuno-Oncology in RCC: Expert Discussion of Frontline Therapy
Episode 12
In this episode, Elizabeth R. Plimack, MD, MS; Brian A. Costello, MD; and Martin H. Voss, MD, discuss current best practices for the first-line treat…
5 years, 7 months ago
Application of New Data in B-Cell Malignancies From ASCO and EHA 2020: Waldenström Macroglobulinemia, Mantle Cell Lymphoma, Hodgkin Lymphoma, and Diffuse Large B-Cell Lymphoma
Episode 11
In this episode, Jennifer R. Brown, MD, PhD, and John Allan, MD, discuss recent key clinical trial results in Waldenström macroglobulinemia, mantle c…
5 years, 7 months ago